Meningococcal Serogroup A, C, W(135) and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands

BACKGROUND: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was introduced in the Netherlands for all children aged 14 months. Despite its success, herd immunity may wane over time. Recently, a serogroup A,C,W135,Y meningococcal conjugate vaccine (MenACWY) was licensed...

Descripción completa

Detalles Bibliográficos
Autores principales: Hepkema, Hiltsje, Pouwels, Koen B., van der Ende, Arie, Westra, Tjalke A., Postma, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669019/
https://www.ncbi.nlm.nih.gov/pubmed/23741448
http://dx.doi.org/10.1371/journal.pone.0065036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669019/
https://www.ncbi.nlm.nih.gov/pubmed/23741448
http://dx.doi.org/10.1371/journal.pone.0065036

Ejemplares similares